Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen
出版年份 2016 全文链接
标题
Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen
作者
关键词
-
出版物
Expert Review of Clinical Pharmacology
Volume 9, Issue 11, Pages 1493-1503
出版商
Informa UK Limited
发表日期
2016-08-07
DOI
10.1080/17512433.2016.1221760
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons
- (2016) Lene Ryom et al. AIDS
- Identification of a novel and severe pattern of efavirenz drug-induced liver injury in South Africa
- (2016) Mark W. Sonderup et al. AIDS
- Bone mineral density decline according to renal tubular dysfunction and phosphaturia in tenofovir-exposed HIV-infected patients
- (2016) José L. Casado et al. AIDS
- Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®
- (2016) Haggar H. Ampadu et al. DRUG SAFETY
- Risk Factors for Incident Diabetes in a Cohort Taking First-Line Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy
- (2016) Sumanth Karamchand et al. MEDICINE
- No Evidence of an Association Between Efavirenz Exposure and Suicidality Among HIV Patients Initiating Antiretroviral Therapy in a Retrospective Cohort Study of Real World Data
- (2016) Ella T. Nkhoma et al. MEDICINE
- Plasma Efavirenz Concentrations Are Associated With Lipid and Glucose Concentrations
- (2016) Phumla Zuleika Sinxadi et al. MEDICINE
- Adverse Drug Reactions Causing Admission to Medical Wards
- (2016) Johannes P. Mouton et al. MEDICINE
- Bone health and HIV in resource-limited settings
- (2016) Flavia Kiweewa Matovu et al. Current Opinion in HIV and AIDS
- Tenofovir and bone health
- (2016) Philip M. Grant et al. Current Opinion in HIV and AIDS
- Hepatitis C virus coinfection as a risk factor for osteoporosis and fracture
- (2016) Roger Bedimo et al. Current Opinion in HIV and AIDS
- Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study
- (2016) Amanda Mocroft et al. Lancet HIV
- Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study
- (2016) Helen Kovari et al. Open Forum Infectious Diseases
- Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease?
- (2015) Jonathan Underwood et al. AIDS
- Proximal Renal Tubular Dysfunction Related to Antiretroviral Therapy Among HIV-Infected Patients in an HIV Clinic in Mexico
- (2015) Karen Andrade-Fuentes et al. AIDS PATIENT CARE AND STDS
- Influence ofABCC2andABCC4Polymorphisms on Tenofovir Plasma Concentrations in Thai HIV-Infected Patients
- (2015) Kanokrat Rungtivasuwan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 Study
- (2015) L Dickinson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Improvement of Depression and Anxiety After Discontinuation of Long- Term Efavirenz Treatment
- (2015) Khutso Mothapo et al. CNS & Neurological Disorders-Drug Targets
- Adverse Drug Reactions Reported to a National HIV & Tuberculosis Health Care Worker Hotline in South Africa: Description and Prospective Follow-Up of Reports
- (2015) Christine Njuguna et al. DRUG SAFETY
- Impaired sperm motility in HIV-infected men: an unexpected adverse effect of efavirenz?
- (2015) C. Frapsauce et al. HUMAN REPRODUCTION
- Comparative Safety and Neuropsychiatric Adverse Events Associated With Efavirenz Use in First-Line Antiretroviral Therapy
- (2015) Nathan Ford et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- No Relationship Between Drug Transporter Genetic Variants and Tenofovir Plasma Concentrations or Changes in Glomerular Filtration Rate in HIV-Infected Adults
- (2015) Wasna Sirirungsi et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Efavirenz and the CNS: what we already know and questions that need to be answered
- (2015) Nadezda Apostolova et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients
- (2015) Qing Ma et al. JOURNAL OF NEUROVIROLOGY
- Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials
- (2015) Paul E Sax et al. LANCET
- Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Polymorphisms associated with renal adverse effects of antiretroviral therapy in a Southern Brazilian HIV cohort
- (2015) Ivete M. da Rocha et al. Pharmacogenetics and Genomics
- A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndrome
- (2015) Amber Dahlin et al. Pharmacogenetics and Genomics
- Tenofovir is associated with increased tubular proteinuria and asymptomatic renal tubular dysfunction in Ghana
- (2015) David R. Chadwick et al. BMC Nephrology
- HIV-associated Neurocognitive Disorders and Antiretroviral Therapy: Current Concepts and Controversies
- (2015) Mark R. Etherton et al. Current Infectious Disease Reports
- Will drug resistance against dolutegravir in initial therapy ever occur?
- (2015) Mark A. Wainberg et al. Frontiers in Pharmacology
- Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis
- (2015) Nathan W. Cummins et al. EBioMedicine
- Antiretroviral Therapy, Especially Efavirenz, Is Associated with Low Bone Mineral Density in HIV-Infected South Africans
- (2015) Joel A. Dave et al. PLoS One
- Antiretrovirals and the kidney in current clinical practice
- (2014) Jean C. Yombi et al. AIDS
- Impact of randomized antiretroviral therapy initiation on glucose metabolism
- (2014) Kristine Mace Erlandson et al. AIDS
- Association Between Efavirenz as Initial Therapy for HIV-1 Infection and Increased Risk for Suicidal Ideation or Attempted or Completed Suicide
- (2014) Katie R. Mollan et al. ANNALS OF INTERNAL MEDICINE
- Long-term treatment with tenofovir: prevalence of kidney tubular dysfunction and its association with tenofovir plasma concentration
- (2014) Marieke Ezinga et al. ANTIVIRAL THERAPY
- Active pharmaceutical ingredients for antiretroviral treatment in low- and middle-income countries: a survey
- (2014) Joseph M Fortunak et al. ANTIVIRAL THERAPY
- Effect of Baseline Renal Function on Tenofovir-Containing Antiretroviral Therapy Outcomes in Zambia
- (2014) Lloyd Mulenga et al. CLINICAL INFECTIOUS DISEASES
- Correlation of CYP2B6-516G>T Polymorphism with Plasma Efavirenz Concentration and Depression in HIV-Infected Adults in Northern Thailand
- (2014) Linda Aurpibul et al. CURRENT HIV RESEARCH
- HIV-1, HCV and Alcohol in the CNS: Potential Interactions and Effects on Neuroinflammation
- (2014) Peter Silverstein et al. CURRENT HIV RESEARCH
- Pure Red Cell Aplasia Induced by Lamivudine without the Influence of Zidovudine in a Patient Infected with Human Immunodeficiency Virus
- (2014) Kiwamu Nakamura et al. INTERNAL MEDICINE
- ABCC2*1C and plasma tenofovir concentration are correlated to decreased glomerular filtration rate in patients receiving a tenofovir-containing antiretroviral regimen
- (2014) W. Manosuthi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Incomplete Reversibility of Estimated Glomerular Filtration Rate Decline Following Tenofovir Disoproxil Fumarate Exposure
- (2014) Sophie Jose et al. JOURNAL OF INFECTIOUS DISEASES
- Impact of Antiretroviral Therapy on Renal Function among HIV-Infected Tanzanian Adults: A Retrospective Cohort Study
- (2014) Bonaventura C. T. Mpondo et al. PLoS One
- Incidence and Determinants of Nevirapine and Efavirenz-Related Skin Rashes in West Africans: Nevirapine's Epitaph?
- (2014) Fred Stephen Sarfo et al. PLoS One
- Diabetes mellitus in HIV-infected patients receiving antiretroviral therapy
- (2014) D Moyo et al. SAMJ SOUTH AFRICAN MEDICAL JOURNAL
- HIV and Aging: Effects on the Central Nervous System
- (2014) Silvia Cañizares et al. SEMINARS IN NEUROLOGY
- Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa
- (2014) Monika Kamkuemah et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- No evident association between efavirenz use and suicidality was identified from a disproportionality analysis using the FAERS database
- (2014) Andrew A Napoli et al. Journal of the International AIDS Society
- Lack of association between use of efavirenz and death from suicide: evidence from the D:A:D study
- (2014) Colette Smith et al. Journal of the International AIDS Society
- Chronic Inflammation and the Role for Cofactors (Hepatitis C, Drug Abuse, Antiretroviral Drug Toxicity, Aging) in HAND Persistence
- (2014) Alexander J. Gill et al. Current HIV/AIDS Reports
- Effects of rifampin-based antituberculosis therapy on plasma efavirenz concentrations in children vary by CYP2B6 genotype
- (2013) Helen M. McIlleron et al. AIDS
- Incident fractures in HIV-infected individuals
- (2013) Stephanie Shiau et al. AIDS
- Relationship Between Weight, Efavirenz Exposure, and Virologic Suppression in HIV-Infected Patients on Rifampin-Based Tuberculosis Treatment in the AIDS Clinical Trials Group A5221 STRIDE Study
- (2013) Anne F. Luetkemeyer et al. CLINICAL INFECTIOUS DISEASES
- Cytochrome P450 pharmacogenetics in African populations
- (2013) Marco Alessandrini et al. DRUG METABOLISM REVIEWS
- Neuronal toxicity of efavirenz: a systematic review
- (2013) Eric H Decloedt et al. Expert Opinion On Drug Safety
- Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs
- (2013) F Gutiérrez et al. HIV MEDICINE
- Dependence of Efavirenz- and Rifampicin-Isoniazid–Based Antituberculosis Treatment Drug-Drug Interaction on CYP2B6 and NAT2 Genetic Polymorphisms: ANRS 12154 Study in Cambodia
- (2013) Julie Bertrand et al. JOURNAL OF INFECTIOUS DISEASES
- HIV, dementia and antiretroviral drugs: 30 years of an epidemic
- (2013) Hadi Manji et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Tenofovir Effect on the Kidneys of HIV-Infected Patients: A Double-Edged Sword?
- (2013) J. Tourret et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients
- (2013) Philip Wikman et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection
- (2013) Sharon L. Walmsley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bone mass, body composition and vitamin D status of ARV-naïve, urban, black South African women with HIV infection, stratified by CD4 count
- (2013) M. M. Hamill et al. OSTEOPOROSIS INTERNATIONAL
- Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent
- (2013) F Aminkeng et al. PHARMACOGENOMICS JOURNAL
- Systematic Review of Antiretroviral-Associated Lipodystrophy: Lipoatrophy, but Not Central Fat Gain, Is an Antiretroviral Adverse Drug Reaction
- (2013) Reneé de Waal et al. PLoS One
- Discontinuation of efavirenz therapy in HIV patients due to neuropsychiatric adverse effects
- (2013) Peter Derek Christian Leutscher et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Fractures after antiretroviral initiation
- (2012) Michael T. Yin et al. AIDS
- Overall benefit of antiretroviral treatment on the risk of fracture in HIV
- (2012) Linda M. Mundy et al. AIDS
- Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents
- (2012) Roger Bedimo et al. AIDS
- High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy
- (2012) Anna Bonjoch et al. ANTIVIRAL RESEARCH
- Clinicopathological correlates in HIV seropositive tuberculosis cases presenting with jaundice after initiating antiretroviral therapy with a structured review of the literature
- (2012) David A Barr et al. BMC INFECTIOUS DISEASES
- Antiretroviral Drug-Related Liver Mortality Among HIV-Positive Persons in the Absence of Hepatitis B or C Virus Coinfection: The Data Collection on Adverse Events of Anti-HIV Drugs Study
- (2012) Helen Kovari et al. CLINICAL INFECTIOUS DISEASES
- Association Between Tenofovir Exposure and Reduced Kidney Function in a Cohort of HIV-Positive Patients: Results From 10 Years of Follow-up
- (2012) C. Laprise et al. CLINICAL INFECTIOUS DISEASES
- Single Nucleotide Polymorphisms in ABCC2 Associate With Tenofovir-Induced Kidney Tubular Dysfunction in Japanese Patients With HIV-1 Infection: A Pharmacogenetic Study
- (2012) T. Nishijima et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and Safety of Rilpivirine (TMC278) Versus Efavirenz at 48 Weeks in Treatment-Naive HIV-1–Infected Patients
- (2012) Calvin J. Cohen et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Liver Enzyme Abnormalities and Associated Risk Factors in HIV Patients on Efavirenz-Based HAART with or without Tuberculosis Co-Infection in Tanzania
- (2012) Sabina Mugusi et al. PLoS One
- Glomerular dysfunction and associated risk factors over 4–5 years following antiretroviral therapy initiation in Africa
- (2011) Wolfgang Stöhr et al. ANTIVIRAL THERAPY
- Current understanding of HIV-associated neurocognitive disorders pathogenesis
- (2011) Patrick Gannon et al. CURRENT OPINION IN NEUROLOGY
- Effect of Nonnucleoside Reverse Transcriptase Inhibitor–Based Antiretroviral Therapy on Dysglycemia and Insulin Sensitivity in South African HIV-Infected Patients
- (2011) Joel A Dave et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Neurocognitive Impact of Substance Use in HIV Infection
- (2011) Desiree A Byrd et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy
- (2011) Frédéric-Antoine Dauchy et al. KIDNEY INTERNATIONAL
- Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial
- (2011) Jan van Lunzen et al. LANCET INFECTIOUS DISEASES
- Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients
- (2011) N. Ciccarelli et al. NEUROLOGY
- High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study
- (2011) G Yimer et al. PHARMACOGENOMICS JOURNAL
- Renal Safety of a Tenofovir-Containing First Line Regimen: Experience from an Antiretroviral Cohort in Rural Lesotho
- (2011) Helen Bygrave et al. PLoS One
- Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naïve patients
- (2011) Leonardo Calza et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Systematic Review and Meta-Analysis of the Tolerability and Hepatotoxicity of Antifungals in Empirical and Definitive Therapy for Invasive Fungal Infection
- (2010) J. L. Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Hypersensitivity reactions to HIV therapy
- (2010) Mas Chaponda et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Systematic Review and Meta‐analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV‐Infected Patients
- (2010) Ryan D. Cooper et al. CLINICAL INFECTIOUS DISEASES
- Raltegravir Versus Efavirenz Regimens in Treatment-Naive HIV-1–Infected Patients: 96-Week Efficacy, Durability, Subgroup, Safety, and Metabolic Analyses
- (2010) Jeffrey L Lennox et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Renal function with use of a tenofovir-containing initial antiretroviral regimen
- (2009) Joel E Gallant et al. AIDS
- Predictors of Kidney Tubular Dysfunction in HIV‐Infected Patients Treated with Tenofovir: A Pharmacogenetic Study
- (2009) Sonia Rodríguez‐Nóvoa et al. CLINICAL INFECTIOUS DISEASES
- Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
- (2009) Jeffrey L Lennox et al. LANCET
- Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study
- (2008) S. De Wit et al. DIABETES CARE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started